Skip Navigation LinksHome > Current Issue > Contributor Index

December 2016 - Volume 27 - Issue 6 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 1 Next
Author Name Article
Amati, Francesca

Acetate is the master of its fate, genetics, and molecular biology bimonthly update

Purchase Access
PDF
+ Favorites
Request Permissions
Baldán, Ángel

Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Barrett, P. Hugh R.

Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Benes, Lane B.

The future of n-3 polyunsaturated fatty acid therapy

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Bertrand, Marie-Jeanne

Pharmacogenomic approaches to lipid-regulating trials

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chan, Dick C.

Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ciccarella, Giuseppe

Trojan horses for drugs: a new role for lipoproteins?

Purchase Access
PDF
+ Favorites
Request Permissions
Cusi, Kenneth

Diabetes medications improve cardiovascular outcomes: the paradigm shifts

Purchase Access
PDF
+ Favorites
Request Permissions
Davidson, Michael H.

The future of n-3 polyunsaturated fatty acid therapy

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Di Bartolo, Belinda A.

Clinical trials with cholesteryl ester transfer protein inhibitors

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Doris, Mhairi K.

The future of imaging in cardiovascular disease intervention trials: 2017 and beyond

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dubé, Marie-Pierre

Pharmacogenomic approaches to lipid-regulating trials

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Duong, MyNgan

Clinical trials with cholesteryl ester transfer protein inhibitors

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dweck, Marc R.

The future of imaging in cardiovascular disease intervention trials: 2017 and beyond

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Farnier, Michel

Proprotein convertase subtilisin kexin type 9 inhibitors: update from clinical trials to real-world experience

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fayad, Zahi A.

The future of imaging in cardiovascular disease intervention trials: 2017 and beyond

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fernández-Hernando, Carlos

Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gidding, Samuel S.

Challenges in the health economics of familial hypercholesterolemia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Groen, Albert K.

Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gryn, Steven E.

New oral agents for treating dyslipidemia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hegele, Robert A.

New oral agents for treating dyslipidemia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kane, John P.

Lipoproteins and amyloid vascular disease

Purchase Access
PDF
+ Favorites
Request Permissions
Kockx, Maaike

Hyperlipidaemia in immunosuppression

Purchase Access
PDF
+ Favorites
Request Permissions
Koopen, Annefleur M.

Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kritharides, Leonard

Hyperlipidaemia in immunosuppression

Purchase Access
PDF
+ Favorites
Request Permissions
Lund, Gertrud

Trojan horses for drugs: a new role for lipoproteins?

Purchase Access
PDF
+ Favorites
Request Permissions
Malloy, Mary J.

Lipoproteins and amyloid vascular disease

Purchase Access
PDF
+ Favorites
Request Permissions
Nicholls, Stephen J.

Clinical trials with cholesteryl ester transfer protein inhibitors

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Nieuwdorp, Max

Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Norman, Richard

Challenges in the health economics of familial hypercholesterolemia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Robinson, Jennifer G.

The future of lipid guidelines

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Stroes, Erik S.G.

HDL infusion for the management of atherosclerosis: current developments and new directions

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Tardif, Jean-Claude

Pharmacogenomic approaches to lipid-regulating trials

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Watts, Gerald F.

Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Challenges in the health economics of familial hypercholesterolemia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Weintraub, William

Challenges in the health economics of familial hypercholesterolemia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Widmann, Christian

Acetate is the master of its fate, genetics, and molecular biology bimonthly update

Purchase Access
PDF
+ Favorites
Request Permissions
Zaina, Silvio

Trojan horses for drugs: a new role for lipoproteins?

Purchase Access
PDF
+ Favorites
Request Permissions
Zheng, Kang H.

HDL infusion for the management of atherosclerosis: current developments and new directions

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 1 Next